| |
| |
|
| Insider
Information: |
Bonita David P |
| Relationship: |
Director, 10% Owner |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
74,794 |
|
|
Indirect Shares
|
56,864,196 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$76,919,547 |
|
|
| Total
Shares |
56,938,990 |
|
|
| Total
Value |
$76,919,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 29.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Loxo Oncology, Inc. |
LOXO |
Director |
2014-08-06 |
0 |
2017-12-08 |
941,000 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Director, 10% Owner |
2017-11-15 |
26,388 |
2017-11-15 |
9,458,567 |
Premium* |
|
|
Tricida, Inc. |
TCDA |
Director, 10% Owner |
2021-11-15 |
27,584 |
2021-11-15 |
10,280,947 |
Premium* |
|
|
Si-Bone, Inc. |
SIBN |
Director |
2018-10-19 |
0 |
2018-10-19 |
985,368 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
Director, 10% Owner |
2020-03-12 |
0 |
2021-07-16 |
4,199,068 |
Premium* |
|
|
Repare Therapeutics Inc. |
RPTX |
Director |
2020-06-23 |
0 |
2021-09-07 |
96,190 |
Premium* |
|
|
Acutus Medical, Inc. |
AFIB |
Director |
2023-06-15 |
20,822 |
2022-06-16 |
6,549,386 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
Director, 10% Owner |
|
0 |
2023-05-22 |
10,646,056 |
Premium* |
|
|
Ikena Oncology, Inc. |
IKNA |
Director |
2021-03-30 |
0 |
2023-08-04 |
7,928,543 |
Premium* |
|
|
Third Harmonic Bio, Inc. |
THRD |
Director, 10% Owner |
2022-09-19 |
0 |
2022-09-19 |
5,779,071 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AFIB |
Acutus Medical, Inc. |
Director |
– • • |
2020-08-10 |
4 |
B |
$18.00 |
$7,470,000 |
I/I |
415,000 |
41,500 |
2.25 |
- |
|
| AFIB |
Acutus Medical, Inc. |
Director |
– • • |
2020-08-10 |
4 |
A |
$0.00 |
$0 |
I/I |
5,062,958 |
1,320,218 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Director |
– • • |
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
206,912 |
|
- |
|
| PRLD |
Prelude Therapeutics Inc |
Director |
– • • |
2020-09-25 |
4 |
B |
$19.00 |
$23,499,200 |
I/I |
1,236,800 |
917,412 |
2.25 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Director |
– • • |
2020-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
8,332,779 |
9,250,191 |
0 |
- |
|
| IKNA |
Ikena Oncology, Inc. |
Director |
– • – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,885,403 |
68,978 |
0 |
- |
|
| IKNA |
Ikena Oncology, Inc. |
Director |
– • – |
2021-03-30 |
4 |
B |
$16.00 |
$6,774,400 |
I/I |
423,400 |
117,378 |
2.1 |
- |
|
| IKNA |
Ikena Oncology, Inc. |
Director |
– • – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
5,214,394 |
130,924 |
0 |
- |
|
| IKNA |
Ikena Oncology, Inc. |
Director |
– • – |
2021-03-30 |
4/A |
A |
$0.00 |
$0 |
I/I |
1,513,486 |
42,614 |
0 |
- |
|
| IKNA |
Ikena Oncology, Inc. |
Director |
– • – |
2021-03-30 |
4/A |
B |
$16.00 |
$6,774,400 |
I/I |
423,400 |
91,014 |
2.1 |
- |
|
| IKNA |
Ikena Oncology, Inc. |
Director |
– • – |
2021-03-30 |
4/A |
A |
$0.00 |
$0 |
I/I |
5,586,311 |
157,288 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • • |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
I/I |
16,403 |
27,584 |
0 |
- |
|
| AFIB |
Acutus Medical, Inc. |
Director |
– • • |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,800 |
4,022 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Director |
– • • |
2021-07-16 |
4/A |
B |
$6.00 |
$9,999,996 |
I/I |
1,666,666 |
4,199,068 |
2.25 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Director |
– • • |
2021-07-16 |
4 |
B |
$6.00 |
$9,999,996 |
I/I |
1,666,666 |
1,666,666 |
2.25 |
- |
|
| AFIB |
Acutus Medical, Inc. |
Director |
– • • |
2021-07-19 |
4 |
B |
$14.00 |
$14,999,992 |
I/I |
1,071,428 |
1,677,361 |
2.25 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-08-17 |
4 |
AS |
$34.12 |
$593,620 |
I/I |
(17,398) |
98,688 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-08-18 |
4 |
AS |
$33.99 |
$99,591 |
I/I |
(2,930) |
98,610 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-08-23 |
4 |
AS |
$34.06 |
$241,622 |
I/I |
(7,094) |
98,401 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-08-24 |
4 |
AS |
$34.07 |
$137,609 |
I/I |
(4,039) |
98,282 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-08-25 |
4 |
AS |
$34.34 |
$243,196 |
I/I |
(7,082) |
98,074 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-08-26 |
4 |
AS |
$34.52 |
$147,849 |
I/I |
(4,283) |
97,948 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-08-27 |
4 |
AS |
$33.94 |
$240,736 |
I/I |
(7,093) |
97,739 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-08-30 |
4 |
AS |
$33.92 |
$227,162 |
I/I |
(6,697) |
97,542 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2021-08-31 |
4 |
AS |
$33.94 |
$287,540 |
I/I |
(8,472) |
97,293 |
0 |
- |
|
65 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
